Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro and Animal Models for Emerging Diseases and Biodefense
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
2/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
Discovery and Target Identification of Senolytic Agents
Developing a novel CGRP antagonist for treatment of dental neuroinflammatory pain
The role of microglia in acute pathology of repeated concussion and CTE development
Bryan County Turning Point Coalition Drug Free Communities Support Program
Recently added grants:
Core C: Data Management and Analysis Core (DMAC)
Core D: Chemistry and Analytical Core (CAC)
Core E: Research Experience and Training Coordination Core (RETCC)
Project 1: Molecular Drivers of Arsenic- Induced Diabetes
Project 2: Arsenic- Obesity- Diabetes Interactions
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI30063-24-0-1
Application #
7580026
Study Section
Project Start
2003-09-30
Project End
2006-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense
/ Southern Research Institute
$6,863,538
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense
/ Southern Research Institute
$351,742
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense
/ Southern Research Institute
$478,964
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense
/ Southern Research Institute
$1,171,784
NIH 2007
N01 AI
Patricia, Cox /
NIH 2007
N01 AI
In Vitro and Animal Models for Emerging Diseases and Biodefense
/
Comments
Be the first to comment on this grant
